NCT05511285 Improving Sleep and Learning in Rehabilitation After Stroke, Part 2
| NCT ID | NCT05511285 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oxford |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-09-13 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-09-13 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will explore whether sleep in stroke survivors is improved with digital cognitive behavioural therapy for insomnia (Sleepio), in comparison to treatment as usual, and will explore whether changes in sleep relate to changes in overnight consolidation of motor learning.
Eligibility Criteria
Inclusion Criteria: * Willing and able to give informed consent for participation in the study * Aged 18 years or above. * Clinical diagnosis of stroke affecting the upper limb, with sufficient movement to perform the motor learning task * Discharged from inpatient care * Interest in accessing a programme with the aim of improving sleep quality * Reliable access to the internet Exclusion Criteria: * Other neurological condition affecting movement (e.g. Parkinson's Disease, Multiple Sclerosis) * Diagnosed, untreated, sleep disorder (e.g. Sleep Apnea) * Uncontrolled seizures * Planned inpatient admission (e.g. for rehabilitation) in the next 4 months that would impact ability to engage with the Sleepio programme * Engagement in psychological therapy for insomnia in the past 12 months * Pregnancy
Contact & Investigator
Melanie K Fleming, Dr
PRINCIPAL INVESTIGATOR
University of Oxford
Frequently Asked Questions
Who can join the NCT05511285 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05511285 currently recruiting?
Yes, NCT05511285 is actively recruiting participants. Contact the research team at melanie.fleming@ndcn.ox.ac.uk for enrollment information.
Where is the NCT05511285 trial being conducted?
This trial is being conducted at Oxford, United Kingdom.
Who is sponsoring the NCT05511285 clinical trial?
NCT05511285 is sponsored by University of Oxford. The principal investigator is Melanie K Fleming, Dr at University of Oxford. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.